Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $57.8 million.

  • Arcturus Therapeutics Holdings' Total Liabilities fell 4688.38% to $57.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.8 million, marking a year-over-year decrease of 4688.38%. This contributed to the annual value of $103.1 million for FY2024, which is 3167.76% down from last year.
  • Latest data reveals that Arcturus Therapeutics Holdings reported Total Liabilities of $57.8 million as of Q3 2025, which was down 4688.38% from $78.2 million recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' 5-year Total Liabilities high stood at $180.1 million for Q4 2022, and its period low was $57.8 million during Q3 2025.
  • Moreover, its 5-year median value for Total Liabilities was $145.5 million (2023), whereas its average is $137.4 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 18807.69% in 2021, then crashed by 4688.38% in 2025.
  • Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Total Liabilities stood at $164.6 million in 2021, then grew by 9.4% to $180.1 million in 2022, then fell by 16.21% to $150.9 million in 2023, then crashed by 31.68% to $103.1 million in 2024, then plummeted by 43.95% to $57.8 million in 2025.
  • Its Total Liabilities was $57.8 million in Q3 2025, compared to $78.2 million in Q2 2025 and $98.0 million in Q1 2025.